Five Markers of AI Readiness in R&D

R&D 中人工智能准备就绪的五个标志

AI readiness doesn't always require a better algorithm. Sometimes, it just requires better data curation and analysis.  

A case study published in PNAS makes the point. Researchers classified nearly 10,000 chemical compounds using a standard machine learning approach and achieved only 10% accuracy. When CAS re-ran the analysis with higher-quality chemical descriptors, accuracy jumped to 45% (median improvement: 33%). Same model, stronger foundation.  

When the data is working harder, research teams can identify top compounds in hours instead of weeks. However, getting there has specific requirements.

[H2] When the AI you stand up falls down

There’s a story that often plays out across scientific R&D teams charged with applying AI to their research. The team:

  • Invests in infrastructure.
  • Hires data scientists.
  • Runs pilots.
  • Tests the AI systems.  
  • Reviews the brilliant test results.  

And only then do they find out that their AI models stumble when encountering real-world conditions. Even worse? The brilliant results never arrive at all, not even within the model.  

The team invests, hires, pilots, tests... and accuracy barely moves. They tweak the algorithm, add more data, adjust parameters. Still nothing. The instinct is to blame the model. But often, the real issues are upstream—and that can include fragmented data silos, inconsistent metadata, varied experimental conditions, incomplete historical records, and the lack of standardized formats across labs or instruments.

Results like that point to a gap in AI readiness.  

Bar chart titled "AI Attitudes Among Chemists." Responses to "AI tools answer scientific questions accurately most of the time" on a 1–5 scale: roughly 20% strongly disagree, 20% disagree, 35% neutral, 15% agree, and 10% strongly agree, indicating overall skepticism among chemists.

Figure 1: Source: C&EN Brand Labs Marketing for the Chemical Sciences Survey Report 2025.

While the team may strengthen their digital infrastructure, they often still struggle to make AI in R&D behave consistently in day-to-day research.

Scientific data frequently varies in structure or quality, and this variation affects how accurately algorithms can interpret the information they receive. As a result, models that perform well in controlled tests often underperform when exposed to the uneven conditions of actual experiments. For example, evaluation datasets can be “too clean” or too similar to training data. They can also fail to reflect real-world noise, outliers, experimental drift, or the full diversity of cases that researchers encounter.

Models trained on incomplete or inconsistent data never perform well in the first place. A lack of domain-specific context in AI pipelines, such as precise chemical ontologies, mechanistic constraints, or expert-curated annotations, can also cause accuracy problems that stem not from data quality itself, but from missing scientific structures. This gap introduces uncertainty, making it challenging to integrate AI into R&D workflows.

This is not just about tweaking current processes to work in a slightly different environment. Preparing to use AI as part of your core R&D infrastructure is a major undertaking. Getting it wrong can waste budgets, cause pilots to fail, discourage leadership from investing the necessary resources, and leave your research scientists skeptical about the benefits.  

[H2] Three areas where organizations struggle to use AI in R&D workflows

Many organizations working to deploy AI in scientific R&D encounter similar operational roadblocks.  

Most of these issues fall into a small set of recurring patterns that limit AI readiness. The following areas represent the most common sources of friction:

1. System alignment becomes a challenge when the tools that store and process scientific data cannot exchange information cleanly. This misalignment typically manifests itself in several ways:

  • ELNs (Electronic Lab Notebooks) and LIMS (Laboratory Information Management Systems) often store information in incompatible formats.
  • Teams must manually adjust records when data moves between systems.
  • Manual adjustments slow pilot work and increase the risk of errors.
  • Pipelines become unstable when metadata is recreated or renamed during transfers.

Together, these breakdowns interrupt the flow of information and prevent models from operating consistently across routine scientific tasks.

2. Manual handoffs and process interruptions erode traceability across the workflow. When data moves between systems or teams through informal channels like exports, emails, and spreadsheets, context gets lost:

  • Records arrive without the metadata needed to interpret them.
  • When a model produces unexpected output, teams struggle to reconstruct how the inputs were generated.
  • It becomes difficult to determine whether an issue originated in the data or in a process gap.
  • Investigations drag on, and scientists spend more time chasing provenance than analyzing results.

Workflow fragmentation creates communication gaps. This is especially costly when data crosses departmental lines. At Calibr-Skaggs, biology and medicinal chemistry teams were manually verifying as many as 1,000 novel compounds per day, slowing go/no-go decisions. CAS streamlined their pipeline with an API integration that let both teams work in parallel, eliminating delays caused by sequential handoffs.

3. Poor coordination across teams can weaken AI readiness over time.

Another common challenge occurs when science, data, and IT groups base their expectations for data structure, standards, and meaning on separate goals, processes and platforms. While some of these disconnects can be as simple as inconsistent rules for naming, versioning, or organizing records, other cases are a result of fundamental differences in meaning. These inconsistencies tend to surface when:

  • Each group applies its own conventions for data definitions, structure, and organization.
  • Differences require substantial manual effort to harmonize, slowing down data flow and introducing opportunities for error.
  • AI teams lack knowledge of upstream differences in standards, resulting in inaccurate and unusable AI solutions.  

Over time, these inconsistencies become more challenging to manage and impact confidence in AI outputs. We’ve observed these types of situations when experimental scientists are tasked with developing a full data strategy yet require additional education to handle various data formats. This is another way in which CAS staff work with partners such as Toray, helping to formalize data governance processes.

[H2] Five markers of AI readiness in R&D

Organizations that are well-positioned to scale AI share a consistent set of workflow characteristics. These five characteristics reflect how effective data, tools, and scientific reviews support models that can accommodate evolving experimental conditions, resolve domain-specific ambiguity, and incorporate continuous changes to underlying knowledge.

1. Data governance that directs scientific and technical decisions

Strong governance is a key marker of AI readiness, as it clarifies the process by which data and model decisions are made. In mature environments, ownership of datasets and their organizing rules are defined, and teams know who is responsible for approving changes to model behavior. These expectations are built into existing scientific workflows, ensuring that decisions occur in the appropriate context.  

It’s also important to maintain a shared log for all datasets and model updates complete with timestamps and rationales to create the audit trail that structured oversight requires. Any changes that affect downstream workflows should also trigger a cross-functional review, ensuring that decisions made in one part of the pipeline don't introduce failures elsewhere.

When governance functions this way, teams can track what changed, why it changed, and how those updates affect AI performance across the R&D workflow.

2. Complete and scientifically meaningful metadata

AI-ready organizations treat metadata as the information that makes scientific records interpretable and actionable. Metadata describes how samples were prepared, how structures were represented, which identifiers were assigned, and where each record originated. High-readiness teams ensure that these details are complete and expressed consistently, so records do not conflict when they are passed between systems. They also maintain a history of how each record evolved. Stable, well-structured metadata enables AI systems to interpret inputs more accurately, reducing the uncertainty that often arises later in the workflow.  

Infographic showing an AI modeling case study. Objective: improve predicted pActivity accuracy for protein-ligand pairs. Approach: replacing a large, noisy public dataset with a smaller, CAS-curated dataset. Impact: error rate dropped from 0.76 to 0.33, achieving 2x better prediction accuracy in re-trained models.



Figure 2: CAS case study showcasing the impact of high-quality, scientist-curated content on the predictive accuracy for the biological activity of a ligand against a protein target. By using CAS-curated content instead of noisy public data, the model increased 2x in prediction accuracy while using a training data set that was half the size of the original.

3. Interoperability across ELNs, LIMS, and model environments

Interoperability is another indicator of readiness, as it reflects how smoothly information flows across R&D systems. In mature environments, data is transmitted through maintained APIs rather than manual transfers, and dataset structures remain consistent as information is exchanged between ELNs, LIMS, and modeling tools. This prevents unexpected changes to fields or labels that would otherwise disrupt pipelines.  

Consistent terminology across systems ensures that records retain their meaning as they move through the workflow. Solutions such as a custom API can apply metadata standards across teams to improve consistency, a strategy that has shown success with drug discovery organizations that have cross-functional teams providing data.

When interoperability functions well, models receive inputs that match real laboratory conditions, which improves stability during deployment.

4. Systems that maintain reliability as workflows evolve

Another sign of AI readiness is an organization's ability to maintain model reliability as data volume increases and scientific knowledge evolves. Mature environments maintain datasets in a versioned state, allowing earlier results to be reproduced, and they retain registries that store the data, configurations, and evaluation results associated with each model. Automated monitoring detects unexpected changes in performance, and configuration logs allow teams to understand how models were created.  

These practices provide visibility into model behavior, which supports informed scientific decision-making as workflows evolve. This also ensures that scientific results and model evaluations can be reproduced months or years later, a requirement for regulatory and publication standards.

5. Human-in-the-loop validation integrated into scientific workflows

AI-ready organizations ensure that scientific review remains at the center of their workflow. Because AI cannot determine whether its predictions align with laboratory conditions, researchers review outputs at defined points to confirm that the results align with experimental expectations. Validation criteria reflect what is feasible in the laboratory and the constraints that apply to the underlying methods. These checks occur before results are passed downstream, and reviewers document the reasoning behind each decision. Regular comparison of predictions with experimental outcomes provides teams with a clearer understanding of how models behave over time and strengthens confidence in their use.


Infographic from molecule.one and CAS comparing synthesis pathway prediction models. Objective: generate accurate pathways for complex molecules using scientist-verified reaction data. Impact: a bar chart shows models trained on CAS data produced over 30% more valid pathways compared to those trained on public USPTO data.

Figure 3: Case study developed in collaboration with Molecule.One. Molecule.One’s retrosynthesis model trained on public reactions data was re-trained using CAS data, leveraging the scientist-curated mappings between reactant and product atoms that are critical to accurate chemical predictions. With CAS data, accurate prediction of valid synthetic routes increased by 30%, as rated by expert synthetic chemists.

综合来看,在上述五个领域进行深思熟虑的改进,可以增强工作流程的一致性,使人工智能能够产出研究人员可以信任并复现的结果。

[Breaker]: 对于正在实施人工智能战略但对数据质量和治理存疑的研究团队,可以 咨询 CAS 专家 ,他们将科学专业知识与数据架构经验相结合,以评估准备情况并识别现有系统中的差距。

[H2] 为 science-smart AI 奠定基础

当人工智能准备好应用于科学 R&D 时,其预测结果能为研究人员提供可 解读、信任并据此采取行动的信息。只有当系统在真实实验的各种变数下都能保持一致的表现,而不仅仅是在受控测试中表现良好时,才算达到这一水平。当模型在面对不同的仪器、格式、条件或工作流程时依然保持稳定,人工智能便从探索性的试点项目转变为能够强化科学决策的实用工具。届时,研究人员可以将人工智能的输出作为日常工作中可预测的一部分,而企业也可以开始将其应用扩展到更广泛的 R&D 管线中。

探索这些原则如何在 CAS Science-Smart AI 资源中转化为实际的 R&D 改进。

Related CAS Insights

AI 药物开发技术的兴起

Defining the path to TBK1 inhibition with QSAR modeling

Embracing the future of AI in the food industry

Gain new perspectives for faster progress directly to your inbox.